Skip to main content
. 2020 Dec 11;9(12):895. doi: 10.3390/antibiotics9120895

Figure 3.

Figure 3

Analysis of recommendations for FUBC sampling in the setting of Gram negative bacteremia on the basis of microbiological factors and efficacy of antibiotic therapy. Note: * MDR definition by Magiorakos AP et al., 2012 [33]; ESBL, extended-spectrum beta-lactamases. References: ineffective therapy in the preceding 24 h [18,21,22,23]; effective therapy in the preceding 24 h [18,21,22,23,24]; preceding positive FUBC [26]; MDR [22,23,25,26]; ESBL+, Serratia spp. and P. aeruginosa [23,24,25]; antibiotic susceptible pathogen [22,23,25,26].